Suven Life Sciences Limited (NSE:SUVEN)
197.00
+19.02 (10.69%)
Apr 10, 2026, 3:30 PM IST
Suven Life Sciences Market Cap
Suven Life Sciences has a market cap or net worth of 51.33 billion as of April 10, 2026. Its market cap has increased by 89.45% in one year.
Market Cap
51.33B
Enterprise Value
48.76B
Revenue
70.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
197.00
Market Cap Chart
Since July 31, 2002, Suven Life Sciences's market cap has increased from 1.61B to 51.33B, an increase of 3,085.43%. That is a compound annual growth rate of 15.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 51.33B | 35.25% |
| Dec 31, 2025 | 37.95B | 35.97% |
| Dec 31, 2024 | 27.91B | 58.69% |
| Dec 29, 2023 | 17.59B | 17.75% |
| Dec 30, 2022 | 14.94B | 31.72% |
| Dec 31, 2021 | 11.34B | -1.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cohance Lifesciences | 121.22B |
| Strides Pharma Science | 91.83B |
| Akums Drugs and Pharmaceuticals | 75.29B |
| Sudeep Pharma | 69.27B |
| Aarti Pharmalabs | 61.73B |
| Sun Pharma Advanced Research Company | 47.44B |
| Innova Captab | 38.96B |
| RPG Life Sciences | 31.21B |